Childhood Cancer Survivorship Passport Challenges in the European Health Data Space.

Cancer EHDS EHRxF European Health Data Space HL7 FHIR Implementation Guide care plans digital health oncology survivor

Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
22 Aug 2024
Historique:
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 23 8 2024
Statut: ppublish

Résumé

Innovation in cancer therapy has increased childhood cancer survival rates. However, survivors are still at risk of developing late effects. In the digital transformation of the health sector, the Survivorship Passport (SurPass) can support long-term follow-up care plans. Gaps in seamless connectivity among hospital departments, primary care, combined with the time of health professionals required to collect and fill-in health data in SurPass, are barriers to its adoption in daily clinical practice. The PanCareSurPass (PCSP) project was motivated to address these gaps by a new version of SurPass (v2.0) that supports semi-automatic assembly from organizational Electronic Health Record (EHR) systems of the treatment summary data using HL7 FHIR, to create SurPass, and to link it to regional or national digital health infrastructures in six European countries. In this paper we present the methodology used to develop the SurPass technical implementation strategy with special focus on the European Health Data Space (EHDS). The recently provisionally approved EHDS regulation instruments a digital health data ecosystem with opportunities for cost-effective SurPass implementation across Europe. Moving forward, a European HL7 FHIR SurPass Implementation Guide along with synthetic data sets, and validation tools can enrich the European Electronic Health Record Exchange Format (EEHRxF) with use cases on health & wellness of childhood cancer survivors.

Identifiants

pubmed: 39176620
pii: SHTI240651
doi: 10.3233/SHTI240651
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1302-1306

Auteurs

Roberta Gazzarata (R)

HL7 Europe, Brussels, Belgium.
Healthropy, Savona, Italy.

Michael Strübin (M)

HL7 Europe, Brussels, Belgium.

Catherine Chronaki (C)

HL7 Europe, Brussels, Belgium.

Giorgio Cangioli (G)

HL7 Europe, Brussels, Belgium.

Davide Saraceno (D)

Cineca Interuniversity Consortium, Bologna, Italy.

Günter Schreier (G)

AIT Austrian Institute of Technology, Wien, Austria.

Stefan Beyer (S)

AIT Austrian Institute of Technology, Wien, Austria.

Florian Trauner (F)

Gesundheit Österreich GmbH, Wien, Austria.

Gerald Gredinger (G)

Gesundheit Österreich GmbH, Wien, Austria.

Ruth Ladenstein (R)

CCRI, Wien, Austria.

Ismay Ae de Beijer (I)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Giacomo Cavalca (G)

IRCCS Istituto Giannina Gaslini, Genova, Italy.
University of Bologna, Bologna, Italy.

Justas Trinkunas (J)

Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

Lucas Cervero Beltran (L)

Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Mark Vanautgaerden (M)

University Hospitals Leuven, KU Leuven, Louvain, Belgium.

Ann-Kristin Kock-Schoppenhauer (AK)

IT Center for Clinical Research, University of Lübeck, Germany.

Anke Neumann (A)

IT Center for Clinical Research, University of Lübeck, Germany.

Monica Muraca (M)

IRCCS Istituto Giannina Gaslini, Genova, Italy.

Anna-Liesa Filbert (AL)

German Childhood Cancer Registry, IMBEI, University Medical Center Mainz, Germany.

Riccardo Haupt (R)

IRCCS Istituto Giannina Gaslini, Genova, Italy.

Desiree Grabow (D)

German Childhood Cancer Registry, IMBEI, University Medical Center Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH